Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharfaraz Salam

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Clinical and Experimental Rheumatology|February 28, 2022
Measuring change in inclusion body myositis: clinical assessments versus imagingLindsay N Alfano, Kendrea L Focht Garand, Georgia A Malandraki, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 3, 2024
Measurement properties of the Inclusion Body Myositis Functional Rating ScaleSharfaraz Salam, Tara Symonds, Helen Doll, et al.
Clinical and Experimental Rheumatology|February 28, 2025
Quantitative muscle magnetic resonance imaging as a biomarker for inclusion body myositis in clinical trials: exploring the in vivo effects of arimoclomolSharfaraz Salam, Jasper M Morrow, Michael P McDermott, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Clinical and Experimental Rheumatology|February 28, 2022
Measuring change in inclusion body myositis: clinical assessments versus imagingLindsay N Alfano, Kendrea L Focht Garand, Georgia A Malandraki, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 3, 2024
Measurement properties of the Inclusion Body Myositis Functional Rating ScaleSharfaraz Salam, Tara Symonds, Helen Doll, et al.
Clinical and Experimental Rheumatology|February 28, 2025
Quantitative muscle magnetic resonance imaging as a biomarker for inclusion body myositis in clinical trials: exploring the in vivo effects of arimoclomolSharfaraz Salam, Jasper M Morrow, Michael P McDermott, et al.
Pageof 2